Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.
Identifieur interne : 000829 ( Main/Exploration ); précédent : 000828; suivant : 000830Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.
Auteurs : David G. Munoz [Canada] ; John M. Woulfe [Canada]Source :
- Neurology [ 1526-632X ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- cerebrospinal fluid : Neovascularization, Pathologic, Parkinson Disease.
- diagnosis : Neovascularization, Pathologic, Parkinson Disease.
- Female, Humans, Male.
DOI: 10.1212/WNL.0000000000002160
PubMed: 26511449
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000366
- to stream PubMed, to step Curation: 000366
- to stream PubMed, to step Checkpoint: 000366
- to stream Ncbi, to step Merge: 001D56
- to stream Ncbi, to step Curation: 001D56
- to stream Ncbi, to step Checkpoint: 001D56
- to stream Main, to step Merge: 000830
- to stream Main, to step Curation: 000829
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.</title><author><name sortKey="Munoz, David G" sort="Munoz, David G" uniqKey="Munoz D" first="David G" last="Munoz">David G. Munoz</name><affiliation wicri:level="1"><nlm:affiliation>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada. munozd@smh.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa</wicri:regionArea><wicri:noRegion>University of Ottawa</wicri:noRegion></affiliation></author><author><name sortKey="Woulfe, John M" sort="Woulfe, John M" uniqKey="Woulfe J" first="John M" last="Woulfe">John M. Woulfe</name><affiliation wicri:level="1"><nlm:affiliation>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa</wicri:regionArea><wicri:noRegion>University of Ottawa</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26511449</idno><idno type="pmid">26511449</idno><idno type="doi">10.1212/WNL.0000000000002160</idno><idno type="wicri:Area/PubMed/Corpus">000366</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000366</idno><idno type="wicri:Area/PubMed/Curation">000366</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000366</idno><idno type="wicri:Area/PubMed/Checkpoint">000366</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000366</idno><idno type="wicri:Area/Ncbi/Merge">001D56</idno><idno type="wicri:Area/Ncbi/Curation">001D56</idno><idno type="wicri:Area/Ncbi/Checkpoint">001D56</idno><idno type="wicri:Area/Main/Merge">000830</idno><idno type="wicri:Area/Main/Curation">000829</idno><idno type="wicri:Area/Main/Exploration">000829</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.</title><author><name sortKey="Munoz, David G" sort="Munoz, David G" uniqKey="Munoz D" first="David G" last="Munoz">David G. Munoz</name><affiliation wicri:level="1"><nlm:affiliation>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada. munozd@smh.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa</wicri:regionArea><wicri:noRegion>University of Ottawa</wicri:noRegion></affiliation></author><author><name sortKey="Woulfe, John M" sort="Woulfe, John M" uniqKey="Woulfe J" first="John M" last="Woulfe">John M. Woulfe</name><affiliation wicri:level="1"><nlm:affiliation>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa</wicri:regionArea><wicri:noRegion>University of Ottawa</wicri:noRegion></affiliation></author></analytic><series><title level="j">Neurology</title><idno type="eISSN">1526-632X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Neovascularization, Pathologic (cerebrospinal fluid)</term><term>Neovascularization, Pathologic (diagnosis)</term><term>Parkinson Disease (cerebrospinal fluid)</term><term>Parkinson Disease (diagnosis)</term></keywords><keywords scheme="MESH" qualifier="cerebrospinal fluid" xml:lang="en"><term>Neovascularization, Pathologic</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Neovascularization, Pathologic</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Munoz, David G" sort="Munoz, David G" uniqKey="Munoz D" first="David G" last="Munoz">David G. Munoz</name></noRegion><name sortKey="Woulfe, John M" sort="Woulfe, John M" uniqKey="Woulfe J" first="John M" last="Woulfe">John M. Woulfe</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000829 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000829 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26511449
|texte= Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26511449" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |